ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
IACTA Pharmaceuticals and Pharmaleads to Develop the World's First Epithelial Protective Drug Harnessing Endogenous Analgesia for the Topical Treatment of Acute and Chronic Ocular Pain
January 08, 2021IACTA Pharmaceuticals, Inc. and Pharmaleads, with Pharmaleads Greater China, today announced they have entered into licensing agreements, with IACTA acquiring global rights to Pharmaleads' Dual Enkephalinase Inhibitors (DENKI®), a novel class of ... -
FDA Approves Dextenza
December 04, 2018FDA Approves Dextenza (dexamethasone ophthalmic insert) for the Treatment of Ocular Pain Following Ophthalmic Surgery.Ocular Therapeutix™, Inc. a biopharmaceutical company focused ....... -
Ocular Therapeutix resubmits Dextenza to FDA seeking approval for post-surgical ocular pain
January 24, 2017Ocular Therapeutix on Monday said it resubmitted Dextenza (dexamethasone) to the FDA seeking approval for the treatment of ocular pain occurring after ophthalmic surgery.
Pharma Sources Insight January 2025
